Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163681 · ClinicalTrials.gov registry record · NA
MRI for Non-Invasive Imaging in Neonates and Children
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02163681 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 45 participants.
The verdict
NCT02163681, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to develop rapid MRI techniques for imaging the lung with hyperpolarized helium-3 gas as an inhaled contrast agent. These techniques will be piloted in adults and older children before testing them in younger children and infants. The purpose is to enable imaging of non-sedated infants by imaging so fast as to freeze motion.
Interventions
- DRUG Hyperpolarized Helium-3 MRI of the chest
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-01-01 |
| Est. Completion | 2018-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02163681
The ClinicalTrials.gov registry entry for NCT02163681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperpolarized Helium-3 MRI of the chest is the first listed.
NCT02163681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02163681 about?
NCT02163681 is a clinical study titled "MRI for Non-Invasive Imaging in Neonates and Children". The purpose of this study is to develop rapid MRI techniques for imaging the lung with hyperpolarized helium-3 gas as an inhaled contrast agent. These techniques will be piloted in adults and older children before testing them in younger children and infants. The purpose is to enable imaging of non-...
What is the current status of trial NCT02163681?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2011-01-01. Estimated completion is 2018-07-30.
What interventions are being tested in trial NCT02163681?
The interventions under investigation include: Hyperpolarized Helium-3 MRI of the chest (DRUG).
Who is sponsoring clinical trial NCT02163681?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.